Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China  被引量:16

Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China

在线阅读下载全文

作  者:Feng-Juan Wang Dai Zhang Zhao-Hui Liu Wen-Xiang Wu Hui-Hui Bai Han-Yu Dong 

机构地区:[1]Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China

出  处:《Chinese Medical Journal》2016年第10期1161-1165,共5页中华医学杂志(英文版)

基  金:Acknowledgements The authors are thankful to all the clinicians and microbiologists for referring vulvovaginal yeast isolates to the mycology reference laboratory. Excellent technical support received from Min Zhao is acknowledged.Financial support and sponsorship This study was supported by a grant from the National Natural Science Foundation of China (No. 81571394).

摘  要:Background: Vulvovaginal candidiasis (WC) was a common infection associated with lifelong harassment of woman's social and sexual life. The purpose of this study was to describe the species distribution and in vitro antifungal susceptibility of Candida species (Candida spp.) isolated from patients with VVC over 8 years. Methods: Species which isolated from patients with VVC in Peking University First Hospital were identified using chromogenic culture media. Susceptibility to common antifungal agents was determined using agar diffusion method based on CLSI M44-A2 document. SPSS software (version 14.0, Inc., Chicago, IL, USA) was used for statistical analysis, involving statistical description and Chi-square test. Results: The most common strains were Candida (C.) albicans, 80.5% (n = 1775) followed by C. glabrata, 18.1% (n = 400). Nystatin exhibited excellent activity against all species (〈4% resistant JR]). Resistance to azole drugs varied among different species. C. albicans: clotrimazole (3.1% R) 〈 fluconazole ( 16.6% R) 〈 itraconazole (51.5% R) 〈 mieonazole (54.0% R), C. glabrata: miconazole (25.6% R) 〈 clotrimazole (50.5% R) 〈 itraconazole (61.9% R) 〈 fluconazole (73.3% R); Candida krusei: clotrimazole (0 R) 〈 fluconazole (57.7% R) 〈 miconazole (73.1% R) 〈 itraconazole (83.3% R). The susceptibility of fluconazole was noticeably decreasing among all species in the study period. Conclusions: Nystatin was the optimal choice for the treatment of VVC at present. The species distribution and in ~'itro antifungal susceptibility of Candida spp. isolated from patients with VVC had changed over time.Background: Vulvovaginal candidiasis (WC) was a common infection associated with lifelong harassment of woman's social and sexual life. The purpose of this study was to describe the species distribution and in vitro antifungal susceptibility of Candida species (Candida spp.) isolated from patients with VVC over 8 years. Methods: Species which isolated from patients with VVC in Peking University First Hospital were identified using chromogenic culture media. Susceptibility to common antifungal agents was determined using agar diffusion method based on CLSI M44-A2 document. SPSS software (version 14.0, Inc., Chicago, IL, USA) was used for statistical analysis, involving statistical description and Chi-square test. Results: The most common strains were Candida (C.) albicans, 80.5% (n = 1775) followed by C. glabrata, 18.1% (n = 400). Nystatin exhibited excellent activity against all species (〈4% resistant JR]). Resistance to azole drugs varied among different species. C. albicans: clotrimazole (3.1% R) 〈 fluconazole ( 16.6% R) 〈 itraconazole (51.5% R) 〈 mieonazole (54.0% R), C. glabrata: miconazole (25.6% R) 〈 clotrimazole (50.5% R) 〈 itraconazole (61.9% R) 〈 fluconazole (73.3% R); Candida krusei: clotrimazole (0 R) 〈 fluconazole (57.7% R) 〈 miconazole (73.1% R) 〈 itraconazole (83.3% R). The susceptibility of fluconazole was noticeably decreasing among all species in the study period. Conclusions: Nystatin was the optimal choice for the treatment of VVC at present. The species distribution and in ~'itro antifungal susceptibility of Candida spp. isolated from patients with VVC had changed over time.

关 键 词:Drug Resistance Infection Diseases Susceptibility Surveillance Vulvovaginal Candidiasis: Women's Health 

分 类 号:S947.2[农业科学—水产养殖] TQ463.53[农业科学—水产科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象